Previous studies have showed that aberrant expressions and altered rhythms of PER1 were highly linked to the carcinogenesis and development of malignant tumors, such as prostate cancer, colon cancer, leukocythemia and breast cancer et al [12]–[17]. This evidence concerns the gene PER1 and prostate cancer.